Почетна › Аутоимуне болести › Северна Каролина
Kliničke studije za Аутоимуне болести u državi Северна Каролина
20 studija za Аутоимуне болести traži učesnike na lokacijama u državi Северна Каролина.
Gradovi u državi Северна Каролина
Zvanični tekst studije (na engleskom)
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1020, Chapel Hill
- Site Number - 1013, Durham
- Site Number - 1044, Raleigh
Тражи се учесникФаза 3
Узраст од 18 до 80 · Оба пола · Ажурирано 13. 11. 2026. · NCT07039916RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill
- Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
Тражи се учесникФаза 2/3
Узраст од 6 до 75 · Оба пола · Ажурирано 13. 11. 2026. · NCT06154252A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
- Duke University Medical Center, Durham
Тражи се учесникФаза 3
Узраст 12 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06056297Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- On Site Clinical Solutions Llc, Charlotte
- Carolina Arthritis Associates, Wilmington
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07621809Study of PTC844 in Participants With Active Rheumatoid Arthritis
- DJL Clinical Research PLLC, Charlotte
Тражи се учесникФаза 2
Узраст од 18 до 70 · Оба пола · Ажурирано 6. 11. 2026. · NCT07779616A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Duke University Hospital, Durham
- East Carolina University, Greenville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06722235A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Atrium Health Rheumatology-Southpark, Charlotte
- Duke University Medical Center, Durham
Тражи се учесникФаза 1
Узраст од 18 до 74 · Оба пола · Ажурирано 2. 11. 2026. · NCT07085104A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Duke University Hospital, Durham
- East Carolina University, Greenville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT06948318Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease
- Site 113, Wilmington
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT07885605A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
- East Carolina University, Greenville
Тражи се учесникФаза 3
Узраст од 18 до 70 · Оба пола · Ажурирано 22. 10. 2026. · NCT07059000Daratumumab in Primary Antiphospholipid Syndrome
- Duke University, Durham
Тражи се учесникФаза 1/2
Узраст од 18 до 65 · Оба пола · Ажурирано 21. 10. 2026. · NCT05671757Environmental Risk Factors for the Anti-synthetase Syndrome
- NIEHS Clinical Research Unit (CRU), Research Triangle Park
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 2 до 100 · Оба пола · Ажурирано 16. 10. 2026. · NCT01276470RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Duke University, Durham
Тражи се учесникФаза 2/3
Узраст од 18 до 75 · Оба пола · Ажурирано 16. 10. 2026. · NCT06328777RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- UNC Chapel Hill, Chapel Hill
Тражи се учесникФаза 1/2
Узраст од 12 до 65 · Оба пола · Ажурирано 6. 10. 2026. · NCT06121297A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Durham
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 8. 9. 2026. · NCT06572384Study of BHV-1300 in Graves' Disease
- Site-108, Greenville
Тражи се учесникФаза 1
Узраст од 18 до 65 · Оба пола · Ажурирано 31. 7. 2026. · NCT06980649A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Duke University, Durham
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 14. 7. 2026. · NCT07115745A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of North Carolina at Chapel Hill, Chapel Hill
- Levine Children's Hospital, Charlotte
- Duke University Medical Center, Durham
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 6. 7. 2026. · NCT01351545A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Duke University Health System, Durham
Тражи се учесникФаза 1
Узраст од 12 до 70 · Оба пола · Ажурирано 22. 5. 2026. · NCT06308978Maternal Autoimmune Disease Research Alliance (MADRA) Registry
- Duke University, Durham
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Сви узрасти · Жене · Ажурирано 8. 1. 2026. · NCT03276923Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.